Ono Pharmaceutical Co Ltd 2020 SR
The report highlights ONO Pharmaceutical's commitment to sustainable social development through innovative drug discovery and strengthened ESG efforts. Key achievements in FY2019 include the formulation of "ECO VISION 2050," aiming for net-zero emissions by 2050, and the approval of science-based targets (SBTi) for greenhouse gas reduction. The company also launched the ONO SWITCH Project, donating savings from work-style reforms to healthcare NPOs. Furthermore, ONO expressed support for TCFD recommendations and joined the RE100 initiative to source 100% renewable energy.
Company: Ono Pharmaceutical Co Ltd
Sector: Health Care
Country: Japan
Year: 2020
Type: SR
Pages: 109
Ono Pharmaceutical Co Ltd
CSR Report
The report highlights ONO Pharmaceutical's commitment to sustainable social development through innovative drug discovery and strengthened ESG efforts. Key achievements in FY2019 include the formulation of "ECO VISION 2050," aiming for net-zero emissions by 2050, and the approval of science-based targets (SBTi) for greenhouse gas reduction. The company also launched the ONO SWITCH Project, donating savings from work-style reforms to healthcare NPOs. Furthermore, ONO expressed support for TCFD recommendations and joined the RE100 initiative to source 100% renewable energy.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 1, 2019 - Mar 31, 2020
Fiscal Year
2019
Published
Sep 1, 2020
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees